Safety and Feasibility of Riociguat Therapy for the Treatment of Chronic Pulmonary Arterial Hypertension in Infancy

被引：9
|
作者：
Giesinger, Regan E. [1 ]
Stanford, Amy H. [1 ]
Thomas, Brady [1 ]
Abman, Steven H. [2 ]
McNamara, Patrick J. [1 ]
机构：
[1] Univ Iowa, Dept Pediat, Iowa City, IA USA
[2] Univ Colorado, Dept Pediat, Denver, CO USA
来源：
JOURNAL OF PEDIATRICS | 2023年 / 255卷
关键词：
SOLUBLE GUANYLATE-CYCLASE; BRONCHOPULMONARY DYSPLASIA; ECHOCARDIOGRAPHY; SILDENAFIL; DISEASE;
D O I：
10.1016/j.jpeds.2022.11.026
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
The effects of riociguat, an oral-soluble guanylate-cyclase stimulator, were studied in 10 infants with chronic pulmonary arterial hypertension. Respiratory status (n = 8/10), right heart dilation (n = 7/10), function (n = 9/10), and chronic pulmonary arterial hypertension (n = 8/10) improved. Median decrement in systolic (12 [4, 14]), diastolic (14 [7, 20]), and mean arterial (14 [10, 17]) pressures were noted; no critical hypotension or hypoxemia occurred.
引用
收藏
页码：224 / +
页数：7
相关论文
共 50 条
  • [41] Riociguat Improves Pulmonary Hemodynamics in Patients with Inoperable Chronic Thromboembolic Pulmonary Hypertension
    Tsai, Cheng-Hsuan
    Wu, Cho-Kai
    Kuo, Ping-Hung
    Hsu, Hsao-Hsun
    Chen, Zheng-Wei
    Hwang, Juey-Jen
    Ko, Chi-Lun
    Huang, Yu-Sen
    Lin, Yen-Hung
    ACTA CARDIOLOGICA SINICA, 2020, 36 (01) : 64 - 71
  • [42] Riociguat use in sickle cell related chronic thromboembolic pulmonary hypertension: A case series
    Weir, Nargues A.
    Conrey, Anna
    Lewis, Denise
    Mehari, Alem
    PULMONARY CIRCULATION, 2018, 8 (04)
  • [43] Diagnosis and treatment of pulmonary hypertension in infancy
    Steinhorn, Robin H.
    EARLY HUMAN DEVELOPMENT, 2013, 89 (11) : 865 - 874
  • [44] Therapy of pulmonary arterial hypertension
    Voswinckel, R.
    Reichenberger, F.
    Gall, H.
    Seeger, W.
    Grimminger, F.
    Ghofrani, H. A.
    INTERNIST, 2009, 50 (09): : 1101 - +
  • [45] Therapy of pulmonary arterial hypertension
    Voswinckel, R.
    Reichenberger, F.
    Gall, H.
    Seeger, W.
    Grimminger, F.
    Ghofrani, H. A.
    INTERNIST, 2009, 50 (09): : 1101 - +
  • [46] Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension
    Kim, Nick H.
    D'Armini, Andrea M.
    Grimminger, Friedrich
    Gruenig, Ekkehard
    Hoeper, Marius M.
    Jansa, Pavel
    Mayer, Eckhard
    Neurohr, Claus
    Simonneau, Gerald
    Torbicki, Adam
    Wang, Chen
    Fritsch, Arno
    Davie, Neil
    Ghofrani, Hossein-Ardeschir
    HEART, 2017, 103 (08) : 599 - 606
  • [47] RIOCIGUAT Soluble Guanylate Cyclase Stimulator Treatment of Pulmonary Hypertension
    Mulligan, C.
    DRUGS OF THE FUTURE, 2009, 34 (06) : 468 - 475
  • [48] RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors
    Hoeper, Marius M.
    Simonneau, Gerald
    Corris, Paul A.
    Ghofrani, Hossein-Ardeschir
    Klinger, James R.
    Langleben, David
    Naeije, Robert
    Jansa, Pavel
    Rosenkranz, Stephan
    Scelsi, Laura
    Gruenig, Ekkehard
    Vizza, Carmine Dario
    Chang, MiKyung
    Colorado, Pablo
    Meier, Christian
    Busse, Dennis
    Benza, Raymond L.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (03)
  • [49] TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
    Gutierrez, Fernando
    Gonzalez, Itamar
    Sanchez Jose, Luis
    Tevar, Enrique
    Vina, Ma Micaela
    Merino, Javier
    ATENCION FARMACEUTICA, 2010, 12 (01): : 39 - 46
  • [50] Ocular toxicity assessment of chronic sildenafil therapy for pulmonary arterial hypertension
    Licia Matieli
    Adriana Berezovsky
    Solange Rios Salomão
    Norma Allemann
    Elisabeth Nogueira Martins
    Flavio E. Hirai
    Jaquelina Ota-Arakaki
    Maira S. A. Morales
    Denise de Freitas
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2016, 254 : 1167 - 1174
12345